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ABSTRACT 
Diabetes mellitus is a major health care issue affecting thousands of 
people each year. As medical research strives for a better understanding of 
diabetes, the life expectancy of diabetics is increasing, and the complications 
associated with this disease process become more evident. Vascular disease 
has specific clinical manifestations as related to diabetes. It is the progression 
of arterial insufficiency in the vascular disease of diabetics that will be 
discussed in this study. The risk factors identified in diabetic vascular disease 
are presented as is their overall effect in the disease process. Current 
concepts of noninvasive vascular testing in the diabetic are addressed. The 
clinical outcome of the diabetic with vascular disease remains guarded, until 





Diabetes mellitus is a major health concern to the individual with the 
disease and to the health care industry. A great deal of research has been 
completed, and is in progress, in search of a cure for diabetes. Although great 
strides have been made in the management of diabetes, the numbers afflicted 
continue to increase, and the complications from the disease become more 
prevalent. 
At present, more than 12 million persons are estimated to have diabetes 
in the United States.1 This figure does not include the large percentage that 
remain undiagnosed. Depending on the study reporting, diabetes is ranked as 
the seventh leading cause of death in Americans.2 Diabetes is the number one 
cause of new cases of blindness and accounts for 50 to 75 percent of all lower 
extremity amputations. The estimated medical costs of caring for patients with 
diabetes escalates yearly and easily exceeds 20 billion dollars per year.3 
The symptoms related to diabetes have been known for centuries and 
appear in literature as far back as 1500 B.C. It was not until 1788 that disease 
or injury to the pancreas was identified as a factor in diabetes. Diabetes 
remained a mystery until the discovery of insulin in 1921.4 At that point, the 
medical field gained a new understanding of diabetes, and treatment became 
much more sophisticated. Physicians thought that with insulin the disease 
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could be controlled, and the diabetic could be expected to live a normal life 
span. However, as diabetics lived longer, it became apparent that they were 
prone to infections. When antibiotics were developed, it was again felt that 
diabetes could be cured with the diabetic leading a normal life. With this 
increase in longevity also came the complications of arteriosclerosis and 
atherosclerosis which appeared earlier in diabetics and more extensively than in 
the general population.5 ,s The complications from vascular disease became, 
and still are, the major cause of morbidity and mortality in the diabetic. 
Considering the effects that arterial insufficiency have on the kidney, retina, and 
peripheral circulation of diabetic patients, the need to understand the 
relationship between diabetes and vascular disease is apparent. Peripheral 
vascular disease is a complex disease in itself and becomes more difficult to 
assess in combination with diabetes. Many theories have emerged to explain 
the increased incidence of vascular disease in diabetics, but several factors 
remain uncertain. 
Diabetes can present with two distinct forms of vascular disease; namely, 
macroangiopathy and microangiopathy? Resulting from thickening and 
obstruction of the larger and medium-sized arteries, macroangiopathy is 
indistinguishable between diabetics and nondiabetics. Microangiopathy, which 
occurs exclusively in diabetics, is a pathologic process in which the capillary 
basement membrane becomes thickened.8 Each diabetic with at least a 20-
year history of diabetes wi" develop vascular disease.9 The progression of 
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vascular disease in the diabetic is evident as a specific disease process with a 
predictable outcome. 
Noninvasive vascular studies have become accepted as a reliable source 
of pertinent information in the evaluation of arterial circulation. Various methods 
have been designed to assess peripheral vascular disease and can be 
described as they apply to the diabetic lower extremity. These studies become 
essential in documenting the progression of vascular disease in the diabetic. 
CHAPTER II 
METHODOLOGY 
In an extensive literature search, the relationship between. diabetes and 
vascular disease is presented in many different aspects. An investigation of the 
contrast between diabetic vascular disease and nondiabetic vascular disease 
does show a varied disease process. The progression of vascular compromise 
in diabetics is defined through various testing procedures as studied in the 
literature review. It can also be shown that there is much controversy 
surrounding attempts to describe vascular lesions of diabetics. These views will , 
be addressed through a review of literature and described with each stage of 
progressive vascular disease in the diabetic. 
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CHAPTER III 
OVERVIEW OF DIABETES MELLITUS 
Diabetes is a disease associated with adverse effects on several systems 
within the body. Metabolic, vascular, and neuropathic disorders all contribute to 
this complex syndrome. The metabolic component is characterized by 
alterations in carbohydrates, fat, and protein metabolism secondary to absent or 
markedly diminished insulin secretion or ineffective insulin action.1 The vascular 
component can be shown to exist as abnormalities of both macropathic and 
micropathic vessels. The neuropathic factor can be related to both metabolic 
and vascular changes. 
The classification of diabetes is listed as a class separate from the other 
categories of glucose intolerance. Diabetes is then subdivided into four 
different types that appear to differ in etiology and pathogenesis. The first type 
is Type I or insulin-dependent diabetes with the presence of ketosis. This 
signifies the almost complete lack of effective insulin.10 Type II or non-insulin-
dependent diabetes represents 90 percent of the diabetic population. Eighty to 
ninety percent of Type II diabetics are obese, which is associated with insulin 
resistance.11 The third type is termed "other" types, which includes several 
pancreatic disorders, drug-induced conditions, and hormonal syndromes that 




Prior to 1979, criteria to diagnose diabetes varied among professionals. 
The World Health Organization then established criteria for a diagnosis based 
on value of a random, fasting, or oral glucose tolerance test. 13 These levels set 
the standard for making a diagnosis of diabetes and establishing protocol for 
treatment. 
Hyperglycemia becomes the only measurable means for the diabetic to 
assess proper control of the disease. The goal for successful treatment would 
be maintaining metabolic control by normalizing blood sugars. The diabetic can 
remain asymptomatic for years, with proper control, until vascular complications 
become evident. 
Type I and Type II diabetes are considered separate disease entities, 
and therefore are managed differently. Although hyperglycemia occurs in both 
Type I and Type II diabetics, the clinical impact is controversial. It should be 
noted that Type I diabetics may be more likely to suffer microvascular 
complications, whereas Type II diabetics may be more likely to have 
macrovascular problems.14 It is generally agreed that chronic hyperglycemia is 
etiologically related to the microvascular complications of diabetes, but it 
probably has less effect on atheromatous changes in the larger arteries.15 The 
controversy as to whether proper diabetic control can prevent or avoid vascular 
complications is extensively addressed in research data, without specific 
consensus. 
CHAPTER IV 
OVERVIEW OF ATHEROSCLEROSIS 
Cardiovascular disease is the chief cause of death in the United States, 
and atherosclerosis, the principle cause of myocardial and cerebral infarction, 
accounts for the majority of these deaths.16 Atherosclerosis is the leading 
cause of chronic lower-extremity ischemia in the majority of patients, even in 
those under 40 years of age.17 Although these facts demonstrate the impact 
that atherosclerosis has on health care, research has not been able to 
accurately define the cause or describe its pathogenesis. 
In an attempt to explain atherosclerosis, arterial lesions have been 
studied thoroughly, and many hypotheses have been developed. The 
response-to-injury hypothesis, the most widely held current view of 
atherogenesis, is that it begins with an injury to the endothelial cell, either from 
hemodynamic or toxic factors.18 With the loss of endothelial cell integrity, there 
is increased protein and lipid permeability in the arterial wall with adherence of 
platelets to the exposed subendothelial collagen. Platelets release a mitogenic 
factor that promotes smooth muscle cell migration and proliferation. This injury, 
an atherosclerotic lesion, progresses and may undergo intraplaque hemorrhage 
or calcification resulting in the typical atherosclerotic plaque. 
The symptoms of lower-extremity arterial insufficiency range from 
claudication to tissue necrosis and gangrene. Kannel19 notes the role of 
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intermittent claudication in the overall management of the general 
cardiovascular status of an individual. In persons with coronary heart disease, 
there is a pronounced increase in risk of claudication. An examination of 
survival rates in men and women who developed unequivocal intermittent 
claudication, in this study, revealed a high mortality. Ten years after diagnosis, 
more than 40 percent of those afflicted, regardless of gender, had died. This 
would suggest that intermittent claudication is a lethal phenomenon. 
Claudication is often the first sign of peripheral vascular disease, and the 
disease process may have been present for years prior to any clinical 
symptoms. Claudication is a hallmark of a generally diseased cardiovascular 
system, and it is the related cardiovascular impairment which shortens the life 
span of the claudication victim.19 
At the cellular and molecular level, research has attempted to identify the 
effects that risk factors have on formation and progression of atherosclerosis. 
These risk factors include smoking, hypertension, hyperlipoproteinemia, and 
diabetes mellitus.20 In the Framingham Heart StudY,21 cigarette smoking was the 
primary risk factor in patients who developed intermittent claudication. Although 
studies clearly support the detrimental effects of smoking in vascular disease, 
the exact mechanism is unknown. Ritz2 describes three theories that have 
been developed to explain how smoking can lead to peripheral vascular 
disease. The first theory suggests that increased levels of carboxyhemoglobin 
cause a loss of oxygen-carrying capacity, resulting in erythrocythemia and an 
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elevated hematocrit. The end result is an increase in blood viscosity and the 
formation of a thrombus. The second theory reports that hypoxia of the inner 
layers of the arterial wall causes an increase in the permeability of the 
endothelium to cholesterol and results in plaque formation. The third 
hypothesis relates smoking to platelet abnormalities, which can lead to 
thrombus formation. For any or all of these proposed theories, smoking 
appears to be an extremely harmful precursor to vascular compromise. 
Patients with hypertension have a greater incidence of atherosclerotic 
complications than the nonhypertensive population. Hypertension has been 
reported to be present in 29 to 39 percent of patients with arteriosclerosis 
obliterans.2o Peripheral vascular disease is twice as common as coronary 
artery disease in hypertensive patients.22 Although the exact effect of 
hypertension on the vascular system is unknown, the control of hypertension 
does seem to be important in slowing the progression of vascular disease. 
Many studies have examined the effect of hypercholesterolemia on 
vascular disease. Present studies indicate that control of cholesterol may 
reverse early arteriosclerotic vascular disease, but once there is far advanced 
disease, the benefit is questionable.20 Low-density lipoproteins are thought to 
contribute to the development of atherosclerosis, while high-density lipoproteins 
are probably protective.23 Measurement of lipid metabolism will need to be 
studied in more detail to determine the importance of lipids as a risk factor. 
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Diabetes, as a risk factor, combines with vascular disease and presents 
as a complex syndrome with a multitude of complications. In research studies, 
diabetics are studied independent of nondiabetics in relationship to vascular 
disease and other risk factor. 
CHAPTER V 
DIABETIC VASCULAR DISEASE 
Vascular complications appear as the major cause of morbidity and 
mortality in diabetic individuals.24 The vascular disease associated with 
diabetes can be subdivided into two general categories: macrovascular disease 
affecting the large arteries and clinically presenting as atherosclerosis; and 
microvascular disease affecting the small arteries and capillaries, which 
clinically presents as diabetic retinopathy and nephropathy, lesions that are 
almost unique to individuals with diabetes.24 
Diabetic microangiopathy is a result of metabolic abnormality caused by 
an absolute or relative insulin deficiency.2 Research is exploring the effect of 
correcting these metabolic abnormalities as a way to prevent or delay the 
development of microvascular disease. Data from studies in animals and 
humans show that strict diabetic control will ameliorate, possibly prevent, and 
even reverse, early microangiopathic changes.25 
Capillary basement membrane thickening is the hallmark of diabetic 
microangiopathy.26 Siperstein27 demonstrated that the protein-based basement 
membrane of small blood vessels thickened in patients with diabetes mellitus. 
Kil028 confirmed this in his study, but also concluded that an association existed 
between the duration of diabetes and the degree of thickening. Other studies 
have shown that excessive levels of blood sugars can result in the formation of 
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glucosylated proteins that resemble the substance responsible for thickening of 
the capillary basement membranes seen in diabetics.4 
Other factors may influence microvascular changes, including the aldose 
reductase and sorbitol pathways. The overuse of glucose by the sorbitol 
pathways in cells that do not require insulin for glucose uptake leads to 
intracellular accumulation of sorbitol, which is of potential importance in 
producing vascular injury.2 The greater the blood glucose level, the more 
sorbitol is formed on the inside of the blood vessels. Aldose reductase, an 
enzyme present in most cells, causes the formation of sorbitol inside cells. This 
process has severe consequences in the peripheral nerves and leads to the 
development of neuropathy, which becomes a critical factor in the rapid 
progression of peripheral arterial disease in the diabetic patient.2 
In addition to studies that relate metabolic control to microvascular 
changes, other hypotheses have been proposed to explain the preponderance 
of vascular disease in diabetics. One hypothesis suggests that there are two 
separate and independent genetic traits; one responsible for the biochemical 
defect, and the other responsible for vascular disease.4 Several studies have 
shown strong evidence in support of genetic predisposition to diabetes, but 
without conclusive results. Another hypothesis proposes an immunologic cause 
of diabetic vascular disease because of the resemblance of small vessel 
disease in diabetics similar to that observed in patients with various immune 
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disorders.4 Any or perhaps all of these factors may have a role in the 
development of microvascular disease and its progression in the diabetic. 
Macrovascular complications in diabetics can be described in comparison 
to nondiabetics. Lower-extremity arterial occlusive disease is twenty times 
more likely to occur in patients with Type" diabetes than in age and sex-
matched control subjects.29 Vascular disease occurs in the diabetic at a much 
younger age. Levin30 reported vascular disease development as early as age 
forty; the male to female ratio of vascular disease being approximately 2 to 1 in 
diabetics compared with 30 to 1 in nondiabetics. 
Although the macrovascular lesions of the diabetic and nondiabetic 
appear the same, the location of the lesions are variable. Strandness8 found 
the pattern of occlusive involvement of the major arteries distinctly different in 
the diabetic than in the nondiabetic. He found a higher incidence of 
involvement below the knee in the anterior tibial, posterior tibial, and peroneal 
arteries of the diabetic. In the diabetic group from the same study, there was 
either stenosis or occlusion of 81 percent of the three major vessels below the 
knee as compared to 57 percent of these vessels in the nondiabetics. More 
evidence comes from surgery cases, as 12 to 17 percent of patients undergoing 
aortoiliac reconstruction are diabetic, whereas 65 to 75 percent of patients 
undergoing femorotibial bypasses are diabetic.4 McMillan31 states that 
obstruction below the knee is prominent in diabetics; whereas in nondiabetics, 
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the obstruction of arterial flow is principally above the knee. This difference 
commonly reduces exercise-associated symptoms in individuals with diabetes. 
The existence of occlusive disease with few or no symptoms contributes 
to limb loss. According to McMillan,31 blood flow in the skin of the foot has 
been known to be increased in diabetics. Nondiabetics have been found to 
reduce their blood flow to the skin of their feet by 80 percent when they stand, 
but many diabetics cannot do this. During standing, artery-wall motion is 
reduced to a minimum because intraluminal arterial pressure in the legs is 
raised by gravity. Popliteal artery blood flow is considerably greater in 
diabetics, setting the stage for local flow disturbances and atherosclerotic 
plaque formation in the branching leg vessels normally protected by low flow. 
Risk factors for diabetic vascular disease are essentially the same as for 
general vascular disease and include age, smoking, hypertension, and certain 
lipoproteins. These factors have an effect on the progression of diabetic 
vascular disease, but the severity may differ depending on the type of diabetes 
and the number of risk factors present in an individual. Other factors, such as 
altered very low density lipoprotein catabolism products, low high density 
lipoprotein cholesterol, and high plasma insulin levels have been postulated to 
contribute to the excess occurrence of atherosclerosis in diabetics.32 Any study 
of risk factors must include identification of the type of diabetes and method of 
management. 
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Age is one of the most important risk factors for peripheral vascular 
disease in diabetics.33 Minaker4 states there is a striking age-related increase 
in the prevalence of diagnosed diabetes, undiagnosed diabetes mellitus, and 
glucose tolerance. Furthermore, he summarizes in his study that aging and 
diabetes express their morbidity through vascular complications, perhaps 
through shared and complimentary pathophysiologic mechanisms. In the . 
discussion of age as a risk factor, duration of diabetes must be addressed. The 
finding of diminished or absent pulses in the lower extremity correlates highly 
with duration of diabetes.33 The duration of diabetes is considered a risk, 
regardless of the degree of control, and correlates strongly with the occurrence 
of vascular calcification.35 Severe calcification is twice as common in short-
duration diabetes mellitus than in the nondiabetic population and four times as 
common in those with long-duration diabetes.5 
Smoking, a certain risk factor for atherosclerosis, is even more potent as 
a risk factor for the diabetic. In a study of 674 subjects, Beach36 found a strong 
relationship between cigarette smoking and severe arteriosclerosis obliterans. 
His study compared types of diabetics and smoking history to severity of 
arteriosclerosis obliterans. The diet-treated diabetic who smoked had the 
highest prevalence of severe arteriosclerosis obliterans. In another study, 
Beach37 determined that the increased prevalence of detectable arteriosclerosis 
obliterans in smokers was highly significant, and evidence of cessation of 
smoking was associated with a decrease in the prevalence of arteriosclerosis 
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obliterans. Strandness38 found a difference among diabetics treated with diet, 
sulfonylurea, or insulin. In the cigarette-smoking diabetic treated by diet, the 
prevalence of arterial disease was two and one-half times that of the insulin-
treated diabetic. 
Conflicting data exist on the importance of hypertension as a risk factor in 
diabetic vascular disease. Studies indicate that there is an increased 
prevalence of hypertension in diabetics. Janka39 showed that peripheral 
vascular disease was closely associated with systolic hypertension and with the 
duration of diabetes. Laaks040 reported in Finland that diabetic patients had 
higher systolic blood pressure and higher frequency of hypertension than 
nondiabetic subjects of either sex. In the Framingham studY,33 hypertension 
was found to be a risk factor for the appearance of intermittent claudication in 
diabetic patients. As these studies indicate, hypertension must be viewed as a 
contributing factor in diabetic vascular disease if not a significant independent 
factor. 
Numerous studies have reviewed the effect of plasma lipids on diabetic 
vascular disease, with the three most important being triglycerides, 
phospholipids, and cholesterol.41 The relationship between high levels of low 
density lipoprotein (LDL) cholesterol and atherogenesis is generally well 
accepted, while high levels of high density lipoprotein (HDL) cholesterol are 
believed to be helpful in slowing the process.5 While this is accepted as a risk 
factor for atherosclerosis, the exact relationship to diabetic complication is 
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uncertain. Hyperglyceridemia has long been known to be highly prevalent in 
the untreated diabetic patient, often accompanied by a decrease in HDL 
cholesterol.41 Uusitupa, et al.,32 in a five-year study of diabetic and nondiabetic 
subjects, found HDL cholesterol lower and very-low density lipoprotein (VLDL) 
cholesterol higher among diabetic patients. 8each42 found similar results and 
determined lipoprotein levels in the diabetics were higher than in an age and 
sex-adjusted nondiabetic group. This study divided insulin-dependent and non-
insulin-dependent diabetics into separate groups which resulted in several other 
differences. VLDL levels were highest in diet-treated subjects followed by 
sulfonylurea-treated subjects. VLDL levels in insulin-treated subjects were not 
elevated. In a recent study, Taskinen43 compared insulin-dependent and non-
insulin-dependent diabetics and found quantitative abnormalities more common 
in the non-insulin-dependent diabetics. The type and management of diabetes 
can relate to metabolic control which is another component to hyperlipidemia 
research. Feingold44 stated there is a direct relationship between indices of 
glycemic control and plasma lipid elevation. 
The levels of plasma lipids and their altered states are currently viewed 
as one factor in the pathogenesis of diabetic vascular disease. Several 
theories have developed to explain the effects of lipoproteins on diabetic 
vessels. Virella4s proposed that the increased levels of modified lipoproteins in 
diabetic patients may be responsible for the accelerated development of 
macrovascular complications associated with the disease. This is thought to 
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occur by the ability of modified lipoproteins to induce the transformation of 
macrophages into foam cells and to induce endothelial cell damage. More 
recently, it was proposed that modified lipoproteins may contribute to 
atherogenesis by yet another mechanism; their ability to trigger an immune 
response leading to the formation of antibodies and subsequently to the 
formation of immune complexes.46 This process suggests that LDL-immune 
complexes may initiate the atherosclerotic process by inducing damage to the 
endothelium and contribute to its progression by inducing foam cell formation 
and proliferation of smooth muscle cells. 
Other factors under review in the pathogenesis of diabetic vascular 
disease are platelet function and blood coagulation and deformability. 
Winocou~7 noted that platelets from diabetics, compared with those from 
nondiabetic subjects, show increased aggregation in response to arachidonate 
pathway, collagen, and thrombin; increased granule release; and increased 
thromboxane production. This may create mural thrombi, which, if organized, 
can incorporate into the vessel wall and further contribute to the atherosclerotic 
development. He also suggests that these thrombi may occlude an already 
narrowed vessel, or they may break away to lodge elsewhere. Kwaan48 noted 
the many abnormalities in soluble coagulation factors and function that occur in 
people with diabetes. He cites the elevation of fibrinogen, which is linked to 
platelet aggregation, blood coagulation, blood flow, and atherogenesis. 
Ambrus49 reported the flexibility of normal red blood cell membrane to be 
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modified toward inflexibility in a number of diseases, including diabetes. This 
creates another factor n the pathogenesis of diabetic vascular disease. 
Amputations are often a predictable outcome for many diabetics. The 
age-adjusted rate of lower-extremity amputations in the diabetic population is 
about 15 times that of the nondiabetic population.50 Once a limb is amputated, 
there is a 30 to 50 percent incidence of gangrene affecting the remaining limb.6 
Jany and Burkus51 reported that after amputation is performed on one leg, the 
contralateral extremity will develop ischemic ulceration within 18 to 36 months in 
50 percent of these patients. Bell35 found that vascular changes leading to 
gangrene occurred 53 times more frequently in diabetic men and 71 times more 
frequently in diabetic women when compared with nondiabetics. These 
statistics provide insight into the prognosis for limb loss in the individual with 
diabetic vascular disease. Perhaps more significant are the statistics based on 
long-term survival following amputation. In the 1970s, studies found a 35 
percent mortality in three years and a 59 percent mortality at the end of five 
years. By 1984, long-term survival following amputation was still poor, with 
studies reporting a 66 percent mortality in two years following amputation.35 
CHAPTER VI 
CLINICAL ASSESSMENT 
The increased incidence and early onset of arterial insufficiency in 
diabetics is well-documented. Many adult-onset diabetic patients have evidence 
of peripheral vascular disease at the time of diagnosis.35 Clinical assessment is 
important for assessing the diabetic with arterial insufficiency and monitoring the 
progress of the disease. 
Noninvasive studies have become accepted as a reliable source of 
pertinent information in the evaluation of vascular disease. A thorough medical 
history and examination become a significant part of noninvasive studies as 
certain conditions can cause a miSinterpretation of results. Different testing 
procedures may be utilized, depending on the data obtained during the history 
taking and physical assessment. 
Segmental pressures, one method of noninvasive testing, are used to 
study progression of vascular disease, to evaluate medical therapy, to 
determine prognosis for healing, and to study prevalence of arterial disease in 
population studies.52 Patients are tested supine with blood pressure cuffs 
placed at the proximal thigh, above the knee, below the knee, and at the ankle. 
Carter2 explains the rationale of interpreting the various pressure readings. 
Starting at the high thigh cuff which determines the aorto-iliac segment, a 
pressure of 20 to 30 mmHg above the arm pressure would be considered 
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normal. Mild gradients of 20 to 3 mmHg lower than arm pressure suggest 
stenosis and larger gradients above 30 mmHg suggest arterial occlusion. A 
difference between any two levels would indicate vascular insufficiency specific 
to the level. Segmental pressures, therefore, reliably localize diseased arterial 
segments and correlate with the severity of clinical ischemia. 
Several studies, including Piecuch and Jaworski53 found the resting 
ankle/brachial pressure index a simple and valuable method of evaluating blood 
supply in the lower extremities. The ankle/brachial systolic pressure ratio or 
pressure index is normally always 1.0 or greater. In patients with symptomatic 
arterial disease, the pressure index is decreased as the severity of symptoms 
increase.54 In diabetics, however, this index may be falsely raised, probably 
due to the presence of medial artery wall calcification.55 Quigley, et al.56 
determined that diabetic subjects have arteries that are less compressible than 
normal arteries, and may make Doppler ankle pressure measurements in 
diabetic subjects misleading over the whole range of pressures recorded. 
Based on the obseNed occurrence of reamputation in association with normal 
or elevated leg/brachial ratios, Emmanuele, et al.57 found that a Doppler 
pressure index above 0.9 is not a reliable indicator of adequate blood flow in 
severe diabetic occlusive arterial disease. CarterS determined that the 
measurement of systolic pressure at the ankle was helpful in determination of 
prognosis in limbs with skin lesions and arterial occlusive disease in the 
nondiabetic patient, but was not reliable in the diabetic patient. Goss, et al.59 
22 
concluded from their study a high prevalence of raised ankle/brachial pressure 
index in insulin-treatment diabetic patients. The increase in the prevalence with 
duration of diabetes in the insulin-treated patients is in agreement with the 
increase in medial calcification found with increased duration of diabetes. The 
presence or severity of peripheral vascular disease may be underestimated in 
patients with an obviously raised ankle pressure. 
The measurement of toe pressure and the resulting toe/ankle and 
toe/brachial pressure indices will identify and quantitate occlusive disease distal 
to the ankle. 60 Toe pressures are especially effective in assessing the diabetic 
limb. Because 5 to 10 percent of diabetic patients with severe peripheral 
vascular disease have markedly elevated ankle pressures due to calcified 
vessels,35 toe pressures provide a better assessment when ankle pressures are 
falsely elevated. Apelqvist, et al.61 concluded from his study that a combination 
of ankle and toe pressure measurements can be used to predict primary 
healing as ankle pressure measurement provided a certain level below which 
healing did not occur, and toe pressure measurement revealed an upper level 
which did not require amputation. Barnes62 studied noninvasive hemodynamics 
on 122 lower-extremity amputations for ischemia. His results determined that 
healing of digit or transmetatarsal amputations was influenced by the presence 
of diabetes and correlated better with digit pulsation and blood pressure than 
with ankle pressure. The frequency of healing in subchronic ulcers with arterial 
occlusive disease was correlated with the systolic digital blood pressure and the 
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systolic ankle blood pressure in a study by Holstein and Lassen.63 Their 
observations, based on initial pressure measurements in combination with the 
final pressure measurements, showed that systolic digital blood pressure is a 
particularly valuable prognostic parameter. Data from this study determined no 
difference between diabetic and nondiabetic feet as to the healing rates. 
With conflicting data based on segmental and toe pressures, particularly 
in reference to diabetes, other methods have been applied to assess overall 
vascular status. Transcutaneous oxygen pressure (TcP02) measurements have 
been utilized to select level of amputation and predict wound healing. Falstie-
Jensen, et al. 64 determined transcutaneous oxygen pressure reliable in 
assessing optimum level of amputation, and failure rate was unrelated to these 
measurements and equal in diabetics and nondiabetics. Burgess, et al.65 
reported that transcutaneous P02 was found to be more consistent with healing 
rates in below-knee amputation than Doppler pressures at the ankle for diabetic 
patients. Lee, et al.,66 in a study comparing TcP02 and photoplethysmograph to 
evaluate the microcirculation status of stumps, found the photoplethysmograph 
technique a valuable adjunct in assessing the healing potential after amputation. 
Vogelberg and Sauerzweig67 studied peripheral vascular disease in diabetics 
with peripheral pulse deficit. The study detected that the quantitative evaluation 
of Doppler velocity measurements seem to be associated with the severity of 
peripheral vascular disease, and compared to oscillography offered advantages 
in the diagnosis of peripheral vascular disease. In a study comparing various 
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methods of noninvasive techniques for effectiveness in predicting amputation 
wound healing, a multivariate analysis of determinants was attempted. The 
authors concluded from their results that for future assessment of healing and 
rehabilitation, a combination of parameters will prove necessary.68 Dependent 
on the clinical status and presence or duration of diabetes, these parameters 
may include Doppler studies, segmental pressure indices, toe pressures, 
photoplethysmography, and transcutaneous P02 measurements. 
CHAPTER VII 
DISCUSSION 
Diabetic vascular disease is difficult to manage as the exact 
pathogenesis remains a mystery. Established risk factors, such as 
hypertension, smoking, and hyperlipidemia, are known to contribute to the 
progression of vascular disease in a diabetic. The controversy on glycemic 
control and its role in developing vascular complications becomes another factor 
to consider in the management of diabetes. Neuropathy, which is prevalent in 
the majority of diabetics to some degree, creates another element of concern to 
the diabetic with vascular disease. All these factors need to be addressed 
when assessing diabetic vascular disease. 
It is estimated that 50 percent of diabetics have evidence of peripheral 
vascular disease 10 to 15 years after the onset of diabetes, and 8 percent of 
adult diabetics already have peripheral arterial disease at the time their diabetes 
is diagnosed.2 These percentages should alert the diabetic population to the 
probability of facing vascular compromise. All forms of impaired glucose 
tolerance increase with advancing age; and there is a striking increase in the 
incidence of diabetes mellitus with advancing age.34 These facts should alert 
the general population to the possibility of facing vascular compromise. 
Diabetics monitor the control of their disease by blood glucose levels, 
and many do not seek medical intervention until they develop evidence of 
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vascular complications. Foot complications account for more hospital days than 
all other diabetic complications combined.69 The care of foot ulcerations in 
diabetics is varied, lengthy, and often unsuccessful, leading to eventual 
amputations. The vascular status is crucial through this process, and should be 
monitored continually. 
Noninvasive testing of arterial flow in lower extremities provides data 
needed to establish the viability of a limb or healing potential. The assessment 
of any areas of ulceration or necrosis, history of stroke or myocardial infarction, 
hypertension, smoking history, and duration and management of diabetes 
provides valuable information in addition to the noninvasive studies. 
When a diabetic presents with obvious vascular disease, as shown by 
clinical assessment, the noninvasive studies, such as segmental pressures or 
Doppler waveforms, can be misleading due to noncompressible vessels. The 
noncompressible vessel will often have a segmental pressure over 250 mmHg, 
but in some diabetic individuals, the pressure may be nearly normal. By clinical 
assessment, it will be obvious that diminished arterial flow is evident, but the 
vessels may be only partially noncompressible revealing higher pressures than 
are actually present. It is difficult, if not impossible, to differentiate between a 
normal vessel and a partially noncompressible vessel by segmental pressure or 
Doppler waveform. Transcutaneous oxygenation monitoring is helpful in these 
cases to provide more insight into actual vascular supply. It then becomes the 
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task of the surgeon to interpret the results of these studies with the clinical 
picture and elect when to do an amputation. 
The progression of vascular disease in a diabetic takes a predestined 
course. If a foot ulcer is present, treatment to heal the ulcer will be 
administered. Depending on clinical assessment and noninvasive studies, 
potential for healing mayor may not be apparent. The diabetic may not seek 
medical consultation until the ulcer has been present for some time, or 
gangrene has developed. Noninvasive studies and clinical assessment are 
essential at this point, not for probability of healing, but to determine level of 
amputation. It should be noted that the progression of the disease continues 
with statistics as mentioned previously, showing involvement in the contralateral 
limb within a few years in the majority of diabetics. 
A primary goal in the management of diabetes should be to slow the 
progression of vascular disease. This can be accomplished through proper 
diabetic teaching. The diabetic must be warned of the severe consequences of 
uncontrolled hypertension, smoking, and hyperlipidemia. The diabetic must also 
be taught to care for his/her feet and the importance of proper footwear. 
Diabetic teaching must be preventative in nature and include the benefits of 
exercise. 
Exercise has been recommended as part of the protocol in the 
management of a diabetic for years. Recently the effects of exercise on 
diabetes and its complications have been reexamined?O-72 The beneficial 
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effects of exercise on cardiovascular disease in normal subjects apply to 
diabetics as well. These benefits might include decreasing VLDL levels, raising 
HDL levels, weight loss, and lowering the risk of heart attack. All these factors 
are of significance to the diabetic and can alter the rate of progressive vascular 
disease. 
Other effects of exercise on diabetes have been studied. 
Hyperinsulinemia has been associated with atherogenic risk factors in 
prediabetic patients; and weight loss and physical activity have been shown to 
increase insulin insensitivity and reduce the risk of diabetes.7o From studies at 
the University of California, Forsham71 stated that exercise helps to lower 
platelet adhesiveness in diabetics, which may reduce the danger of thrombotic 
phenomena. Physical training also seems to improve glycemic control.72 The 
positive impact exercise has on the individual with diabetes reinforces the goal 
of incorporating exercise into the management of diabetes. 
CHAPTER VIII 
CONCLUSION 
Diabetic vascular disease is progressive and creates a dismal prognosis 
for the individual afflicted. Research has addressed atherosclerosis and 
diabetes from many different prospectives, searching for clues to the 
pathogenesis of each. The study of lipid metabolism and lipoprotein 
modifications has provided insight into atherosclerosis as it relates to diabetes. 
The study of platelets and coagulation abnormalities has resulted in a better 
understanding of hemodynamics in diabetes and vascular disease. These 
findings show progress in research efforts, describing the association between 
diabetes and atherosclerosis, but research has made minimal advances in 
defining the accelerated rate of vascular disease in the diabetic. 
Amputation is an inevitable consequence of diabetic vascular disease, 
given sufficient age or duration of diabetes. The reality of this must be 
emphasized in diabetic teaching in hopes of reducing noncompliance. 
Controlling risk factors and promoting a healthy lifestyle appear to be the best 
approach to the overall management of diabetes and vascular disease. 
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